Dr. Oliver Mutschlechner
Chief Executive Officer (CEO), Founder
PhD and MSc in Biochemistry / Biotechnology (Technical University of Vienna, Austria)
25 years of professional experience in development of biologics in research, pharma and biotech (Companies: Octapharma, Intercell, Apeiron)
Positions in R&D, QC/QA, qualified person, regulatory affairs, manufacturing and executive management
Strong focus on projects and company goals in the field of vaccine development, oncology/immuno-oncology and hematology
Strong background in generating value by successful transition from early development to global commercialization